Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Will direct team of formulation scientists who develop oral solid dose formulations for Phase I through Phase III clinical trials.
April 15, 2021
By: Tim Wright
Editor-in-Chief, Contract Pharma
Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, has appointed Stephanie Emory, PhD as associate director of pharmaceutical development. In that capacity, Stephanie directs a team of formulation scientists who develop oral solid dose formulations for Phase I through Phase III clinical trials, and then scale up and support the validation and commercialization of those products. Additionally, she oversees Metrics’ Pharmaceutical Development Lab—the fast track/small scale specialty lab that focuses on quick-start formulation development and analytical testing. In this capacity, she evaluates new technologies that can benefit client-sponsored programs. Stephanie reports to Brad Gold, vice president of pharmaceutical development for Metrics Contract Services. “Dr. Emory is a proven leader in the CDMO space, and she comes with a strong background in product development and specifically, bioavailability enhancement of small molecule formulations,” said Gold. “Her diverse skill sets will enhance our product development expertise as well as increase productivity by ensuring the efficient management of resources. She will be an effective and strategic leader who will help manage a broad spectrum of vital projects.” Stephanie comes to Metrics Contract Services most recently from the FDA where she reviewed the CMC/Drug Product portions of INDs, NDAs, and industry meeting packages for CDER’s Office of Pharmaceutical Quality. Prior to FDA she spent seven years at UPM Pharmaceuticals, a then Baltimore-based CDMO, serving as both technical lead and project manager for the development of Pre-clinical through Phase III clinical supplies. She has experience with a wide range of solid oral dosage forms and manufacturing processes, including solubility-enhancing formulations, as well as scale-up, tech transfer, and process validation activities. Emory holds a Bachelor of Science in Pharmaceutical Sciences and a doctorate in Industrial & Physical Pharmacy from Purdue University.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !